Share Price and Basic Stock Data
Last Updated: January 21, 2026, 6:40 pm
| PEG Ratio | 0.26 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Tainwala Chemicals & Plastics (India) Ltd operates in the plastics sector, specifically focusing on sheets and films. The company reported a market capitalization of ₹170 Cr and a share price of ₹182. In terms of revenue, Tainwala’s sales demonstrated significant fluctuations, recording ₹12.83 Cr for FY 2023 and rising to ₹18.03 Cr for FY 2024. However, the trailing twelve months (TTM) revenue stood at ₹16.32 Cr, indicating a decline from the previous fiscal year. Quarterly sales figures varied considerably, with the highest quarterly sales of ₹8.14 Cr in March 2023, followed by a drop to ₹6.48 Cr in June 2023 and further to ₹6.36 Cr in September 2023. This volatility in revenue highlights the company’s challenges in maintaining consistent sales growth. The company’s operating profit margin (OPM) fluctuated significantly, with a TTM OPM of 5.73%, reflecting ongoing operational inefficiencies. Overall, while Tainwala has shown capacity for revenue generation, the inconsistency raises concerns about sustainable growth.
Profitability and Efficiency Metrics
Tainwala Chemicals & Plastics reported a net profit of ₹7.40 Cr, with a return on equity (ROE) of 3.31% and return on capital employed (ROCE) of 4.24%. The company’s operating profit margin (OPM) fluctuated between negative and positive values, standing at 5.73% in the latest analysis. The operating profit was negative in multiple quarters, particularly in March 2023, where it stood at -₹4.17 Cr. The company recorded a cash conversion cycle (CCC) of 64.09 days, indicating that Tainwala is managing its working capital efficiently compared to typical industry standards. However, the ROE and ROCE figures are relatively low, suggesting that the company struggles to generate substantial returns for its shareholders. Despite these challenges, Tainwala has maintained a zero-borrowing stance, enhancing its financial stability, but the overall profitability metrics indicate the need for operational improvements and cost management strategies.
Balance Sheet Strength and Financial Ratios
The balance sheet of Tainwala Chemicals & Plastics reflects a strong financial position, with total assets amounting to ₹188.43 Cr and no borrowings recorded. The reserves increased significantly, reaching ₹162.66 Cr by September 2025, which indicates a robust capital base. The company’s interest coverage ratio (ICR) stood impressively at 54.94x, showcasing its ability to cover interest expenses comfortably, although it has not incurred any interest expenses in recent years. Moreover, the price-to-book value (P/BV) ratio at 0.40x suggests that the stock is undervalued compared to its book value, potentially presenting a buying opportunity for investors. However, the low return metrics indicate that while the company is financially stable, it may not be utilizing its assets and capital effectively to generate higher returns. The overall financial ratios indicate a balance between stability and operational challenges that need to be addressed.
Shareholding Pattern and Investor Confidence
Tainwala’s shareholding pattern reveals a high degree of promoter ownership at 67.45%, which indicates strong management control and alignment with shareholder interests. The presence of institutional investors is minimal, with Foreign Institutional Investors (FIIs) holding 0.05% and Domestic Institutional Investors (DIIs) at 0.22%. The public shareholding stands at 32.27%, with a total of 8,335 shareholders as of September 2025. The slight increase in promoter holdings over the previous periods reflects management confidence in the company’s future prospects. However, the low participation from institutional investors may suggest some hesitance regarding the company’s growth trajectory and profitability. Enhanced transparency and performance improvements could help attract more institutional interest, which would foster greater investor confidence and potentially lead to higher valuations in the future.
Outlook, Risks, and Final Insight
The outlook for Tainwala Chemicals & Plastics is contingent on its ability to stabilize revenue and improve operational efficiency. The company faces risks from fluctuating sales, as evidenced by the considerable variations in quarterly results, which could hinder long-term growth. Additionally, while the balance sheet is strong, the low profitability ratios present challenges in generating adequate returns for shareholders. On the positive side, the absence of debt and growing reserves provide a cushion against financial stress, allowing for potential investments in growth initiatives. Moving forward, Tainwala must focus on enhancing its operational efficiency and exploring new market opportunities to improve its financial performance. Should it successfully implement strategic changes, Tainwala could emerge as a more competitive player in the plastics sector, attracting both institutional investors and enhancing shareholder value.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hindustan Adhesives Ltd | 152 Cr. | 297 | 410/281 | 8.37 | 200 | 0.00 % | 17.2 % | 18.0 % | 10.0 |
| G M Polyplast Ltd | 87.5 Cr. | 65.0 | 138/61.5 | 12.0 | 31.7 | 0.00 % | 28.8 % | 21.0 % | 10.0 |
| Duropack Ltd | 29.2 Cr. | 55.4 | 105/54.3 | 17.8 | 41.1 | 0.00 % | 10.3 % | 8.09 % | 10.0 |
| Command Polymers Ltd | 24.0 Cr. | 25.6 | 41.8/25.6 | 42.8 | 13.2 | 0.00 % | 4.73 % | 3.64 % | 10.0 |
| Bansal Roofing Products Ltd | 136 Cr. | 103 | 135/81.3 | 17.8 | 26.8 | 0.97 % | 22.4 % | 18.2 % | 10.0 |
| Industry Average | 491.67 Cr | 95.23 | 18.26 | 70.82 | 0.36% | 14.04% | 11.51% | 7.70 |
All Competitor Stocks of Tainwala Chemicals & Plastics (India) Ltd
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.18 | 1.74 | 8.14 | 6.48 | 6.36 | 4.40 | 0.79 | 1.55 | 4.97 | 4.59 | 5.31 | 1.01 | 5.41 |
| Expenses | 2.19 | 1.68 | 12.31 | 6.64 | 6.28 | 4.43 | 0.91 | 1.27 | 5.08 | 4.02 | 4.76 | 1.05 | 5.10 |
| Operating Profit | -1.01 | 0.06 | -4.17 | -0.16 | 0.08 | -0.03 | -0.12 | 0.28 | -0.11 | 0.57 | 0.55 | -0.04 | 0.31 |
| OPM % | -85.59% | 3.45% | -51.23% | -2.47% | 1.26% | -0.68% | -15.19% | 18.06% | -2.21% | 12.42% | 10.36% | -3.96% | 5.73% |
| Other Income | 3.83 | 3.57 | 1.82 | 0.55 | 5.38 | 0.51 | -0.24 | 0.79 | 3.77 | 0.57 | 0.26 | 3.09 | 5.06 |
| Interest | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.11 | 0.07 | 0.10 | 0.10 | 0.10 | 0.09 | 0.09 | 0.09 |
| Profit before tax | 2.70 | 3.51 | -2.48 | 0.26 | 5.34 | 0.37 | -0.43 | 0.97 | 3.56 | 1.03 | 0.72 | 2.96 | 5.28 |
| Tax % | 10.00% | 0.00% | 13.71% | 0.00% | 11.61% | 27.03% | 2.33% | 18.56% | 4.21% | 84.47% | 23.61% | 5.07% | 26.52% |
| Net Profit | 2.44 | 3.51 | -2.82 | 0.26 | 4.72 | 0.27 | -0.44 | 0.79 | 3.42 | 0.16 | 0.55 | 2.81 | 3.88 |
| EPS in Rs | 2.61 | 3.75 | -3.01 | 0.28 | 5.04 | 0.29 | -0.47 | 0.84 | 3.65 | 0.17 | 0.59 | 3.00 | 4.14 |
Last Updated: January 10, 2026, 10:33 am
Below is a detailed analysis of the quarterly data for Tainwala Chemicals & Plastics (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 5.41 Cr.. The value appears strong and on an upward trend. It has increased from 1.01 Cr. (Jun 2025) to 5.41 Cr., marking an increase of 4.40 Cr..
- For Expenses, as of Sep 2025, the value is 5.10 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.05 Cr. (Jun 2025) to 5.10 Cr., marking an increase of 4.05 Cr..
- For Operating Profit, as of Sep 2025, the value is 0.31 Cr.. The value appears strong and on an upward trend. It has increased from -0.04 Cr. (Jun 2025) to 0.31 Cr., marking an increase of 0.35 Cr..
- For OPM %, as of Sep 2025, the value is 5.73%. The value appears strong and on an upward trend. It has increased from -3.96% (Jun 2025) to 5.73%, marking an increase of 9.69%.
- For Other Income, as of Sep 2025, the value is 5.06 Cr.. The value appears strong and on an upward trend. It has increased from 3.09 Cr. (Jun 2025) to 5.06 Cr., marking an increase of 1.97 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 0.09 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.09 Cr..
- For Profit before tax, as of Sep 2025, the value is 5.28 Cr.. The value appears strong and on an upward trend. It has increased from 2.96 Cr. (Jun 2025) to 5.28 Cr., marking an increase of 2.32 Cr..
- For Tax %, as of Sep 2025, the value is 26.52%. The value appears to be increasing, which may not be favorable. It has increased from 5.07% (Jun 2025) to 26.52%, marking an increase of 21.45%.
- For Net Profit, as of Sep 2025, the value is 3.88 Cr.. The value appears strong and on an upward trend. It has increased from 2.81 Cr. (Jun 2025) to 3.88 Cr., marking an increase of 1.07 Cr..
- For EPS in Rs, as of Sep 2025, the value is 4.14. The value appears strong and on an upward trend. It has increased from 3.00 (Jun 2025) to 4.14, marking an increase of 1.14.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:33 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8.27 | 9.73 | 9.44 | 5.73 | 11.48 | 11.53 | 10.58 | 6.47 | 7.72 | 12.83 | 18.03 | 16.42 | 16.32 |
| Expenses | 8.91 | 10.73 | 11.85 | 8.11 | 14.37 | 14.93 | 12.56 | 8.90 | 11.43 | 18.26 | 19.12 | 15.15 | 14.93 |
| Operating Profit | -0.64 | -1.00 | -2.41 | -2.38 | -2.89 | -3.40 | -1.98 | -2.43 | -3.71 | -5.43 | -1.09 | 1.27 | 1.39 |
| OPM % | -7.74% | -10.28% | -25.53% | -41.54% | -25.17% | -29.49% | -18.71% | -37.56% | -48.06% | -42.32% | -6.05% | 7.73% | 8.52% |
| Other Income | 1.73 | 3.88 | 6.89 | 9.74 | 9.69 | 5.64 | 6.86 | 2.62 | 4.81 | 9.77 | 7.06 | 5.40 | 8.98 |
| Interest | 0.02 | 0.02 | 0.10 | 0.08 | 0.04 | 0.04 | 0.03 | 0.04 | 0.35 | 0.01 | 0.01 | 0.01 | 0.01 |
| Depreciation | 0.71 | 0.76 | 0.52 | 0.54 | 0.39 | 0.41 | 0.50 | 0.48 | 0.38 | 0.44 | 0.42 | 0.38 | 0.37 |
| Profit before tax | 0.36 | 2.10 | 3.86 | 6.74 | 6.37 | 1.79 | 4.35 | -0.33 | 0.37 | 3.89 | 5.54 | 6.28 | 9.99 |
| Tax % | 16.67% | 3.33% | 0.26% | 0.00% | 0.00% | -15.08% | 0.46% | 0.00% | 0.00% | 15.68% | 13.18% | 21.66% | |
| Net Profit | 0.30 | 2.03 | 3.86 | 6.74 | 6.37 | 2.05 | 4.34 | -0.32 | 0.37 | 3.28 | 4.81 | 4.92 | 7.40 |
| EPS in Rs | 0.32 | 2.17 | 4.12 | 7.20 | 6.80 | 2.19 | 4.63 | -0.34 | 0.40 | 3.50 | 5.14 | 5.25 | 7.90 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 576.67% | 90.15% | 74.61% | -5.49% | -67.82% | 111.71% | -107.37% | 215.62% | 786.49% | 46.65% | 2.29% |
| Change in YoY Net Profit Growth (%) | 0.00% | -486.52% | -15.54% | -80.10% | -62.33% | 179.53% | -219.08% | 323.00% | 570.86% | -739.84% | -44.36% |
Tainwala Chemicals & Plastics (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 9% |
| 3 Years: | 29% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 1% |
| 3 Years: | 50% |
| TTM: | 30% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 35% |
| 3 Years: | 25% |
| 1 Year: | 3% |
| Return on Equity | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 1% |
| 3 Years: | 3% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 1:41 pm
Balance Sheet
Last Updated: December 4, 2025, 2:04 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9.36 | 9.36 | 9.36 | 9.36 | 9.36 | 9.36 | 9.36 | 9.36 | 9.36 | 9.36 | 9.36 | 9.36 | 9.36 |
| Reserves | 29.71 | 31.21 | 35.07 | 57.96 | 66.09 | 67.61 | 76.42 | 88.59 | 80.88 | 89.36 | 108.18 | 144.26 | 162.66 |
| Borrowings | 0.00 | 0.00 | 0.80 | 0.36 | 0.18 | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 1.26 | 1.55 | 1.35 | 1.71 | 1.66 | 2.45 | 2.95 | 2.36 | 1.31 | 0.72 | 5.66 | 13.53 | 16.41 |
| Total Liabilities | 40.33 | 42.12 | 46.58 | 69.39 | 77.29 | 79.42 | 88.77 | 100.31 | 91.55 | 99.44 | 123.20 | 167.15 | 188.43 |
| Fixed Assets | 3.99 | 2.71 | 3.30 | 3.24 | 2.94 | 3.11 | 2.70 | 2.72 | 2.94 | 3.58 | 3.16 | 2.78 | 2.59 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 19.52 | 20.73 | 25.08 | 46.69 | 52.61 | 53.55 | 62.82 | 80.70 | 74.38 | 88.76 | 117.18 | 159.80 | 178.83 |
| Other Assets | 16.82 | 18.68 | 18.20 | 19.46 | 21.74 | 22.76 | 23.25 | 16.89 | 14.23 | 7.10 | 2.86 | 4.57 | 7.01 |
| Total Assets | 40.33 | 42.12 | 46.58 | 69.39 | 77.29 | 79.42 | 88.77 | 100.31 | 91.55 | 99.44 | 123.20 | 167.15 | 188.43 |
Below is a detailed analysis of the balance sheet data for Tainwala Chemicals & Plastics (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 9.36 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 9.36 Cr..
- For Reserves, as of Sep 2025, the value is 162.66 Cr.. The value appears strong and on an upward trend. It has increased from 144.26 Cr. (Mar 2025) to 162.66 Cr., marking an increase of 18.40 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 16.41 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13.53 Cr. (Mar 2025) to 16.41 Cr., marking an increase of 2.88 Cr..
- For Total Liabilities, as of Sep 2025, the value is 188.43 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 167.15 Cr. (Mar 2025) to 188.43 Cr., marking an increase of 21.28 Cr..
- For Fixed Assets, as of Sep 2025, the value is 2.59 Cr.. The value appears to be declining and may need further review. It has decreased from 2.78 Cr. (Mar 2025) to 2.59 Cr., marking a decrease of 0.19 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 178.83 Cr.. The value appears strong and on an upward trend. It has increased from 159.80 Cr. (Mar 2025) to 178.83 Cr., marking an increase of 19.03 Cr..
- For Other Assets, as of Sep 2025, the value is 7.01 Cr.. The value appears strong and on an upward trend. It has increased from 4.57 Cr. (Mar 2025) to 7.01 Cr., marking an increase of 2.44 Cr..
- For Total Assets, as of Sep 2025, the value is 188.43 Cr.. The value appears strong and on an upward trend. It has increased from 167.15 Cr. (Mar 2025) to 188.43 Cr., marking an increase of 21.28 Cr..
Notably, the Reserves (162.66 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.64 | -1.00 | -3.21 | -2.74 | -3.07 | -3.40 | -2.02 | -2.43 | -3.71 | -5.43 | -1.09 | 1.27 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 24.72 | 88.91 | 103.24 | 70.07 | 52.14 | 20.58 | 85.90 | 135.39 | 24.59 | 18.21 | 8.30 | 23.79 |
| Inventory Days | 261.55 | 139.70 | 168.06 | 394.27 | 167.16 | 208.52 | 179.74 | 280.66 | 239.23 | 73.92 | 33.16 | 42.57 |
| Days Payable | 11.71 | 27.28 | 19.41 | 72.35 | 32.09 | 55.65 | 83.09 | 97.47 | 18.80 | 4.60 | 2.30 | 2.27 |
| Cash Conversion Cycle | 274.56 | 201.32 | 251.89 | 391.99 | 187.21 | 173.44 | 182.56 | 318.59 | 245.01 | 87.53 | 39.16 | 64.09 |
| Working Capital Days | 185.37 | 174.81 | 271.82 | 348.44 | 211.43 | 218.11 | 176.98 | 306.89 | 189.12 | 93.31 | 41.70 | 57.13 |
| ROCE % | 0.39% | 3.94% | 8.28% | 11.16% | 8.49% | 1.77% | 5.25% | -1.26% | -3.17% | 2.74% | 4.24% | 4.24% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 14 | Mar 13 |
|---|---|---|
| FaceValue | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.32 | 0.64 |
| Diluted EPS (Rs.) | 0.32 | 0.64 |
| Cash EPS (Rs.) | 1.08 | 0.00 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 41.73 | 0.00 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 41.73 | 0.00 |
| Revenue From Operations / Share (Rs.) | 8.99 | 0.00 |
| PBDIT / Share (Rs.) | 1.16 | 0.00 |
| PBIT / Share (Rs.) | 0.40 | 0.00 |
| PBT / Share (Rs.) | 0.38 | 0.00 |
| Net Profit / Share (Rs.) | 0.32 | 0.00 |
| NP After MI And SOA / Share (Rs.) | 0.32 | 0.00 |
| PBDIT Margin (%) | 12.92 | 13.88 |
| PBIT Margin (%) | 4.52 | 6.18 |
| PBT Margin (%) | 4.29 | 6.01 |
| Net Profit Margin (%) | 3.58 | 6.05 |
| NP After MI And SOA Margin (%) | 3.58 | 6.05 |
| Return on Networth / Equity (%) | 0.77 | 0.00 |
| Return on Capital Employeed (%) | 0.96 | 0.00 |
| Return On Assets (%) | 0.74 | 0.00 |
| Current Ratio (X) | 7.78 | 0.00 |
| Quick Ratio (X) | 3.05 | 0.00 |
| Interest Coverage Ratio (X) | 54.94 | 36.83 |
| Interest Coverage Ratio (Post Tax) (X) | 16.23 | 37.05 |
| Enterprise Value (Cr.) | 14.65 | 0.00 |
| EV / Net Operating Revenue (X) | 1.74 | 0.00 |
| EV / EBITDA (X) | 13.47 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 1.90 | 0.00 |
| Price / BV (X) | 0.40 | 0.00 |
| Price / Net Operating Revenue (X) | 1.90 | 0.00 |
| EarningsYield | 0.01 | 0.00 |
After reviewing the key financial ratios for Tainwala Chemicals & Plastics (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 14, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 13) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 14, the value is 0.32. This value is below the healthy minimum of 5. It has decreased from 0.64 (Mar 13) to 0.32, marking a decrease of 0.32.
- For Diluted EPS (Rs.), as of Mar 14, the value is 0.32. This value is below the healthy minimum of 5. It has decreased from 0.64 (Mar 13) to 0.32, marking a decrease of 0.32.
- For Cash EPS (Rs.), as of Mar 14, the value is 1.08. This value is below the healthy minimum of 3. It has increased from 0.00 (Mar 13) to 1.08, marking an increase of 1.08.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 14, the value is 41.73. It has increased from 0.00 (Mar 13) to 41.73, marking an increase of 41.73.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 14, the value is 41.73. It has increased from 0.00 (Mar 13) to 41.73, marking an increase of 41.73.
- For Revenue From Operations / Share (Rs.), as of Mar 14, the value is 8.99. It has increased from 0.00 (Mar 13) to 8.99, marking an increase of 8.99.
- For PBDIT / Share (Rs.), as of Mar 14, the value is 1.16. This value is below the healthy minimum of 2. It has increased from 0.00 (Mar 13) to 1.16, marking an increase of 1.16.
- For PBIT / Share (Rs.), as of Mar 14, the value is 0.40. This value is within the healthy range. It has increased from 0.00 (Mar 13) to 0.40, marking an increase of 0.40.
- For PBT / Share (Rs.), as of Mar 14, the value is 0.38. This value is within the healthy range. It has increased from 0.00 (Mar 13) to 0.38, marking an increase of 0.38.
- For Net Profit / Share (Rs.), as of Mar 14, the value is 0.32. This value is below the healthy minimum of 2. It has increased from 0.00 (Mar 13) to 0.32, marking an increase of 0.32.
- For NP After MI And SOA / Share (Rs.), as of Mar 14, the value is 0.32. This value is below the healthy minimum of 2. It has increased from 0.00 (Mar 13) to 0.32, marking an increase of 0.32.
- For PBDIT Margin (%), as of Mar 14, the value is 12.92. This value is within the healthy range. It has decreased from 13.88 (Mar 13) to 12.92, marking a decrease of 0.96.
- For PBIT Margin (%), as of Mar 14, the value is 4.52. This value is below the healthy minimum of 10. It has decreased from 6.18 (Mar 13) to 4.52, marking a decrease of 1.66.
- For PBT Margin (%), as of Mar 14, the value is 4.29. This value is below the healthy minimum of 10. It has decreased from 6.01 (Mar 13) to 4.29, marking a decrease of 1.72.
- For Net Profit Margin (%), as of Mar 14, the value is 3.58. This value is below the healthy minimum of 5. It has decreased from 6.05 (Mar 13) to 3.58, marking a decrease of 2.47.
- For NP After MI And SOA Margin (%), as of Mar 14, the value is 3.58. This value is below the healthy minimum of 8. It has decreased from 6.05 (Mar 13) to 3.58, marking a decrease of 2.47.
- For Return on Networth / Equity (%), as of Mar 14, the value is 0.77. This value is below the healthy minimum of 15. It has increased from 0.00 (Mar 13) to 0.77, marking an increase of 0.77.
- For Return on Capital Employeed (%), as of Mar 14, the value is 0.96. This value is below the healthy minimum of 10. It has increased from 0.00 (Mar 13) to 0.96, marking an increase of 0.96.
- For Return On Assets (%), as of Mar 14, the value is 0.74. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 13) to 0.74, marking an increase of 0.74.
- For Current Ratio (X), as of Mar 14, the value is 7.78. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 13) to 7.78, marking an increase of 7.78.
- For Quick Ratio (X), as of Mar 14, the value is 3.05. This value exceeds the healthy maximum of 2. It has increased from 0.00 (Mar 13) to 3.05, marking an increase of 3.05.
- For Interest Coverage Ratio (X), as of Mar 14, the value is 54.94. This value is within the healthy range. It has increased from 36.83 (Mar 13) to 54.94, marking an increase of 18.11.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 14, the value is 16.23. This value is within the healthy range. It has decreased from 37.05 (Mar 13) to 16.23, marking a decrease of 20.82.
- For Enterprise Value (Cr.), as of Mar 14, the value is 14.65. It has increased from 0.00 (Mar 13) to 14.65, marking an increase of 14.65.
- For EV / Net Operating Revenue (X), as of Mar 14, the value is 1.74. This value is within the healthy range. It has increased from 0.00 (Mar 13) to 1.74, marking an increase of 1.74.
- For EV / EBITDA (X), as of Mar 14, the value is 13.47. This value is within the healthy range. It has increased from 0.00 (Mar 13) to 13.47, marking an increase of 13.47.
- For MarketCap / Net Operating Revenue (X), as of Mar 14, the value is 1.90. This value is within the healthy range. It has increased from 0.00 (Mar 13) to 1.90, marking an increase of 1.90.
- For Price / BV (X), as of Mar 14, the value is 0.40. This value is below the healthy minimum of 1. It has increased from 0.00 (Mar 13) to 0.40, marking an increase of 0.40.
- For Price / Net Operating Revenue (X), as of Mar 14, the value is 1.90. This value is within the healthy range. It has increased from 0.00 (Mar 13) to 1.90, marking an increase of 1.90.
- For EarningsYield, as of Mar 14, the value is 0.01. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 13) to 0.01, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Tainwala Chemicals & Plastics (India) Ltd:
- Net Profit Margin: 3.58%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.96% (Industry Average ROCE: 14.04%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.77% (Industry Average ROE: 11.51%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 16.23
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.05
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 21.3 (Industry average Stock P/E: 18.26)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.58%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plastics - Sheets/Films | Tainwala House, Road No. 18, Mumbai Maharashtra 400093 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ramesh Tainwala | Chairman & Managing Director |
| Ms. Upasana Babel | Director - Finance & CFO |
| Mr. Rakesh Tainwala | Non Executive Director |
| Mr. Uday Ramniklal Mehta | Independent Director |
| Mr. Devendra Saligram Anand | Independent Director |
| Mr. Ketan Dhirajlal Barai | Independent Director |
FAQ
What is the intrinsic value of Tainwala Chemicals & Plastics (India) Ltd?
Tainwala Chemicals & Plastics (India) Ltd's intrinsic value (as of 21 January 2026) is ₹191.88 which is 16.29% higher the current market price of ₹165.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹158 Cr. market cap, FY2025-2026 high/low of ₹319/155, reserves of ₹162.66 Cr, and liabilities of ₹188.43 Cr.
What is the Market Cap of Tainwala Chemicals & Plastics (India) Ltd?
The Market Cap of Tainwala Chemicals & Plastics (India) Ltd is 158 Cr..
What is the current Stock Price of Tainwala Chemicals & Plastics (India) Ltd as on 21 January 2026?
The current stock price of Tainwala Chemicals & Plastics (India) Ltd as on 21 January 2026 is ₹165.
What is the High / Low of Tainwala Chemicals & Plastics (India) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Tainwala Chemicals & Plastics (India) Ltd stocks is ₹319/155.
What is the Stock P/E of Tainwala Chemicals & Plastics (India) Ltd?
The Stock P/E of Tainwala Chemicals & Plastics (India) Ltd is 21.3.
What is the Book Value of Tainwala Chemicals & Plastics (India) Ltd?
The Book Value of Tainwala Chemicals & Plastics (India) Ltd is 184.
What is the Dividend Yield of Tainwala Chemicals & Plastics (India) Ltd?
The Dividend Yield of Tainwala Chemicals & Plastics (India) Ltd is 1.81 %.
What is the ROCE of Tainwala Chemicals & Plastics (India) Ltd?
The ROCE of Tainwala Chemicals & Plastics (India) Ltd is 4.24 %.
What is the ROE of Tainwala Chemicals & Plastics (India) Ltd?
The ROE of Tainwala Chemicals & Plastics (India) Ltd is 3.31 %.
What is the Face Value of Tainwala Chemicals & Plastics (India) Ltd?
The Face Value of Tainwala Chemicals & Plastics (India) Ltd is 10.0.